Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 1 of 13, showing 5 Applications out of 65 total, starting on record 1, ending on 5

# Protocol No Study Title Investigator(s) & Site(s)

1.

ECCT/26/02/07   IMPAACT 2024
    Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age with and without HIV   
Principal Investigator(s)
1. LUCY Chepkurui Koech
Site(s) in Kenya
Kenya Medical Research Institute/Walter Reed Project(KEMRI/WRP)
 
View

2.

ECCT/26/04/02   IGHID 12430/DELIVER-02
    IGHID12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY   
Principal Investigator(s)
1. Charity Wambui Kanyoro
Site(s) in Kenya
1. Moi University Clinical Research Centre(MUCRC), Eldoret, Kenya (Uasin Gishu county)
2. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county)
 
View

3.

ECCT/25/11/02   DELIVER-02
    IGHID 12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY   
Principal Investigator(s)
1. Deborah Chepngeno Langat
Site(s) in Kenya
1. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county)
2. MOI UNIVERSITY CLINICAL RESEARCH CENTRE (MUCRC), ELDORET (Uasin Gishu county)
 
View

4.

ECCT/25/07/01   FIH Study of CLY-124
    A Phase 1, Randomized, Placebo-Controlled, Double Blind, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CLY-124 in Healthy Volunteers and Participants with Sickle Cell Disease   
Principal Investigator(s)
1. Bernhards Ogutu
Site(s) in Kenya
1. Strathmore University Medical Center [SUMC], Creates for Research in Therapeutic Sciences (Nairobi City county)
2. Victoria Biomedical Research Institute [VIBRI] (Kisumu county)
 
View

5.

ECCT/25/04/07   Server migration
    Server Migration   
Principal Investigator(s)
1. Server Migration Server Migration
Site(s) in Kenya
Server Migration
 
View